Week43, 2021
1. Influenza activity remains low nationwide, with 0.2% of clinical specimens and an increasing number of public health specimens testing positive for influenza in recent weeks.
2. Of the 52 clinical lab-positive specimens, 65.4% were Influenza A and 34.6% were Influenza B.
3. Public health labs reported 35 positive specimens, with 91.4% being Influenza A, primarily H3N2, and 8.6% Influenza B, mostly of the Victoria lineage.
4. Outpatient visits for influenza-like illness (ILI) accounted for 1.9% of visits, below the national baseline of 2.5%; activity levels were minimal across most of the U.S.
5. No pediatric deaths associated with influenza have been reported during the 2021-22 season.
6. Pneumonia, influenza, or COVID-19 (PIC) accounted for 15.6% of deaths, exceeding the epidemic threshold, with most attributed to COVID-19.
7. Hospital surveillance reported 282 influenza-confirmed hospitalizations nationwide, though cumulative hospitalization rates remain unavailable.
8. No significant vaccination trends were reported, though CDC emphasizes annual flu vaccinations as the best preventive measure.
9. Respiratory illness trends show stability, with ILI trends unchanged across all age groups over the past four weeks.
10. Flu activity could increase in coming weeks as the number of detected influenza cases rises steadily, while healthcare-seeking changes during COVID-19 may affect surveillance interpretation.